These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 21625223

  • 21. Long-range oncogenic activation of Igh-c-myc translocations by the Igh 3' regulatory region.
    Gostissa M, Yan CT, Bianco JM, Cogné M, Pinaud E, Alt FW.
    Nature; 2009 Dec 10; 462(7274):803-7. PubMed ID: 20010689
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.
    Bassing CH, Ranganath S, Murphy M, Savic V, Gleason M, Alt FW.
    Blood; 2008 Feb 15; 111(4):2163-9. PubMed ID: 17855626
    [Abstract] [Full Text] [Related]

  • 24. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
    Nepal RM, Zaheen A, Basit W, Li L, Berger SA, Martin A.
    Oncogene; 2008 Aug 07; 27(34):4752-6. PubMed ID: 18408759
    [Abstract] [Full Text] [Related]

  • 25. Role of AID in tumorigenesis.
    Okazaki IM, Kotani A, Honjo T.
    Adv Immunol; 2007 Aug 07; 94():245-73. PubMed ID: 17560277
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y, Friedmann D, Sonoda E, Jung S, Rajewsky K, Eilat D.
    J Immunol; 1998 Nov 01; 161(9):4634-45. PubMed ID: 9794392
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations.
    Haines BB, Ryu CJ, Chang S, Protopopov A, Luch A, Kang YH, Draganov DD, Fragoso MF, Paik SG, Hong HJ, DePinho RA, Chen J.
    Cancer Cell; 2006 Feb 01; 9(2):109-20. PubMed ID: 16473278
    [Abstract] [Full Text] [Related]

  • 34. Pathways that suppress programmed DNA breaks from progressing to chromosomal breaks and translocations.
    Franco S, Alt FW, Manis JP.
    DNA Repair (Amst); 2006 Sep 08; 5(9-10):1030-41. PubMed ID: 16934538
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.
    Bassing CH, Suh H, Ferguson DO, Chua KF, Manis J, Eckersdorff M, Gleason M, Bronson R, Lee C, Alt FW.
    Cell; 2003 Aug 08; 114(3):359-70. PubMed ID: 12914700
    [Abstract] [Full Text] [Related]

  • 37. Myc translocations in B cell and plasma cell neoplasms.
    Janz S.
    DNA Repair (Amst); 2006 Sep 08; 5(9-10):1213-24. PubMed ID: 16815105
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification.
    Difilippantonio MJ, Petersen S, Chen HT, Johnson R, Jasin M, Kanaar R, Ried T, Nussenzweig A.
    J Exp Med; 2002 Aug 19; 196(4):469-80. PubMed ID: 12186839
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.